Cite
APA Citation
Oyama, K., Raz, I., Cahn, A., Goodrich, E., Bhatt, D., Leiter, L., McGuire, D., Wilding, J., Gause-Nilsson, I., Mosenzon, O., Sabatine, M., & Wiviott, S. (n.d.). influence of cardiovascular drugs on the efficacy and safety of dapagliflozin in patients with type 2 diabetes mellitus in the DECLARE-TIMI 58 trial. European heart journal, 42, . http://access.bl.uk/ark:/81055/vdc_100144498139.0x000057